PPARD and Arthritis: In a collagen-induced mouse model of arthritis, mice receiving MSCs with reduced PPAR-δ activity (MSCs harvested from PPAR-δ knockout mice or WT PPAR-δ MSCs pretreated with the PPAR-δ antagonist GSK3787) had better suppression of inflammatory immune responses, leading to improvements in arthritis scores [61].